Replies to post #6794 on Shell Stocks; Reverse Mergers; Acquisitions; Zombi

[Potse]

GSAC(.0033)...cannabis IP, contract manufacturing......

Added a few more shares to my position. GSAC continues to be a largely under-followed sub-penny play with connections to the cannabis sector. GSAC's involvement in the cannabis sector comes in the form of its contract manufacturing business (gum, lozenges, confectionery products, etc), pending patents on its manufacturing processes, and its own proprietary brands of CBD-infused products.

The stock is trading at a pretty steep discount to the 7 cent share price it was trading at when it acquired Mastix Medica in 2014.

GelStat Corporation is engaged in the development, manufacturing, marketing and branding of innovative Cannabidiol (CBD) infused over-the-counter (OTC) consumer healthcare products addressing very large markets. The Company's strategy is to build shareholder value through organic growth and strategic acquisitions.

http://www.otcmarkets.com/stock/gsac/profile

We contract manufacture or private label tableted chewing gum, chew-able tablets, lozenges, mints and candy for a wide variety of customers including national brand leaders, small niche marketers, the U.S. Military, export customers and many more. Our product capabilities include dietary supplements, functional chewing gum, medicated chewing gum, functional foods and confectionery, medicated confectionery and compressed dextrose or sugar-free candy – almost anything that can be tableted we can make.

http://mastixmedica.com/

MedCBDX is an innovative CBD-ceutical company focused on enhancing everyday life through the most efficiently metabolized ways of consumption.

http://medcbdx.com/

https://mobile.twitter.com/MedCbdx?p=s